Citius Pharmaceuticals, Inc. Share Price & Technical Analysis
CTXR · $0.67 (-4.29%)
Healthcare / Biotechnology
$0.67
-4.29%
Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA-approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company's late-stage pipeline includes Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections; Halo-L…
Price chart
Seasonality
May has 0 positive and 4 negative years (last 5 years shown)
0% return in May, -11% avg return in past 3 year May month.
-6% return in 2026, -36% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -12% | 0% | 29% | -22% | 0% | – | – | – | – | – | – | – | -6% |
| 25 | -32% | -41% | -12% | -38% | -12% | 129% | -12% | 0% | -8% | 33% | -12% | -43% | -50% |
| 24 | -18% | 22% | 19% | -18% | -3% | -17% | 49% | -38% | -13% | -26% | -65% | 21% | -88% |
| 23 | 72% | -18% | 1% | 24% | -18% | 3% | -18% | -7% | -24% | 11% | 1% | -1% | 29% |
| 22 | -4% | 1% | 17% | -44% | -6% | -1% | -3% | 39% | -1% | -13% | 8% | -33% | -40% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Neutral
Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA-approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company's late-stage pipeline includes Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections; Halo-Lido, a corticosteroid-lidocaine topical formulation to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; and NoveCite, a mesenchymal stem cell therapy for the treatment of ARDS. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$16.80M
P/E ratio
—
52W high
$2.48
52W low
$0.48
Volume
85,054
Beta
1.05
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Citius Pharmaceuticals, Inc. share price today?
- Citius Pharmaceuticals, Inc. (CTXR) last traded around $0.67 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does CTXR have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for CTXR. Download the app for real-time alerts.
- How can I analyze Citius Pharmaceuticals, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.